The Continuing Fascination with Jaks and Stats: An Introduction



The origins of the discovery of Jak-Stat signal transduction date back to the late 1980s when research groups headed by Jim Darnell, Ian Kerr and George Stark were fascinated by the fact that gene transcription could be induced within minutes after treating cells with type I interferons (IFN-I). The speed with which a signal generated by the plasma membrane–associated IFN-I receptor travelled to nuclear target genes suggested few intermediate steps. The Darnell, Kerr and Stark labs identified bifunctional signal transducers and activators of transcription (Stats) as responsible for IFN-induced transcription by using complementary biochemical and genetic approaches (reviewed in Darnell et al. 1994). Shortly after this seminal discovery, the labs of Sandra Pellegrini, Jim Ihle and Christine Carter-Su independently identified non-receptor protein tyrosine kinases (pTK) in the signaling pathways stimulated by, respectively, the IFN, erythropoietin and growth hormone receptors (Argetsinger et al. 1993; Velazquez et al. 1992; Witthuhn et al. 1993). The same kinases had previously emerged from screens for novel pTKs, conducted in the labs of John Krolewski and Andrew Wilks and named Janus kinases by the latter (Firmbach-Kraft et al. 1990; Wilks et al. 1991). With recombinant Jaks and Stats at hand it was possible to reconstitute IFN signaling between receptor and nuclear targets with just two components: receptor associated Jaks that activate Stats by tyrosine phosphorylation. Tyrosine phosphorylated Stats localize to the cell nucleus and bind to promoter DNA of specific target genes (Fig. 1).


Tyrosine Phosphorylation Growth Hormone Receptor Specific Target Gene Massive Parallel Sequencing Antiviral State 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Argetsinger LS, Campbell GS, Yang X, Witthuhn BA, Silvennoinen O, Ihle JN, Carter Su C (1993) Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237–244PubMedCrossRefGoogle Scholar
  2. Darnell JE Jr, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415–1421PubMedCrossRefGoogle Scholar
  3. Firmbach-Kraft I, Byers M, Shows T, Dalla-Favera R, Krolewski JJ (1990) tyk2, prototype of a novel class of non-receptor tyrosine kinase genes. Oncogene 5:1329–1336PubMedGoogle Scholar
  4. Velazquez L, Fellous M, Stark GR, Pellegrini S (1992) A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 70:313–322PubMedCrossRefGoogle Scholar
  5. Wilks AF, Harpur AG, Kurban RR, Ralph SJ, Zurcher G, Ziemiecki A (1991) Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. Mol Cell Biol 11:2057–2065PubMedGoogle Scholar
  6. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN (1993) JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227–236PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2012

Authors and Affiliations

  1. 1.Department of Microbiology, Immunobiology and Genetics, Max F. Perutz LaboratoriesUniversity of ViennaViennaAustria
  2. 2.Institute of Animal Breeding and GeneticsUniversity of Veterinary Medicine ViennaViennaAustria
  3. 3.Biomodels AustriaUniversity of Veterinary Medicine ViennaViennaAustria

Personalised recommendations